Ingrid Hass
University of East Anglia(GB)Royal London Hospital(GB)Clinical Trial Investigators(US)University College London(GB)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, Sepsis Diagnosis and Treatment, Pneumonia and Respiratory Infections, Intensive Care Unit Cognitive Disorders, interferon and immune responses
Most-Cited Works
- → Landiolol and Organ Failure in Patients With Septic Shock(2023)83 cited
- → INHALE WP3, a multicentre, open-label, pragmatic randomised controlled trial assessing the impact of rapid, ICU-based, syndromic PCR, versus standard-of-care on antibiotic stewardship and clinical outcomes in hospital-acquired and ventilator-associated pneumonia(2025)30 cited
- → Immunophenotyping patients with sepsis and underlying haematological malignancy reveals defects in monocyte and lymphocyte function(2024)2 cited
- → Cost-effectiveness of rapid, ICU-based, syndromic PCR in hospital-acquired pneumonia: analysis of the INHALE WP3 multi-centre RCT(2025)2 cited
- → The effects of ultra-selective beta1-antagonism on the metabolic and cytokine profile in septic shock patients receiving noradrenaline: a sub-investigation from the STRESS-L Randomised Study(2025)1 cited
- → Correction: Cost-effectiveness of rapid, ICU-based, syndromic PCR in hospital-acquired pneumonia: analysis of the INHALE WP3 multi-centre RCT(2025)